WASHINGTON (Reuters) - Senior managers from some of the world's largest over-the-counter (OTC) derivatives firms, currently accustomed to little government scrutiny, are scheduled to testify on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback